Pharmacologic treatments for covid-19 patients

Ivermectin+Doxycycline vs Standard care/Placebo

This comparison will not be updated. Last search date 28 Feb, 2022.


Hospitalized patients

Forest plots
(last update: 2021-07-22)

Summary of findings
(last update: 2022-05-04)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=134

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
NCT04591600
Hashim A, medRxiv, 2020
Full text
Commentary
Commentary
Public/non profit

IVM+DX

Standard care

RCT Outpatients and inpatients with COVID-19 (unclear severity) treated at 2 centers in Iraq N=140
High
Details

Full description

NCT04407130
Ahmed S, Int J Infect Dis, 2020
Full text
32506-6/fulltext Commentary
Private

IVM+DX

Ivermectin

Ivermectin

Placebo

RCT Patients with confirmed COVID-19 (mild) admitted to hospital in Bangladesh. N=72
Some concerns
Details

Full description

NCT04523831
Mahmud R, J Int Med Res, 2021
Full text
Commentary
No specific funding

IVM+DX

Placebo

RCT Outpatients and inpatients with confirmed COVID-19 (ambulatory-mild-moderate) admitted to a single center in Bangladesh N=400
Some concerns
Details

Full description